Cat FIP Antiviral Treatment Advanced: GS-441524 Outcomes

Antiviral treatments including GS-441524 have transformed feline infectious peritonitis from a uniformly fatal disease to one that is curable in most cases. This is one of the greatest recent advances in feline welfare.

Key Facts

FIP was considered uniformly fatal until antiviral treatments became available around 2019
GS-441524 and mutian X achieve remission in approximately 85-90% of treated cats
Treatment requires 12 weeks of daily oral or injectable medication
Relapse after treatment occurs in approximately 10-15% of cases and can be retreated
Licensed remdesivir-based treatments are now available in some countries
FIP was previously a leading cause of death in young cats under 3 years of age

Welfare Considerations

The transformation of FIP from invariably fatal to largely curable represents one of the most significant feline welfare advances of the 21st century. Cats with FIP experience rapid deterioration including fluid accumulation, neurological signs and progressive organ failure. Antiviral treatment achieves remission in the majority of cases, allowing cats that would previously have died within weeks to live normal lives. Access to affordable licensed treatment remains a welfare challenge in many countries.

What You Can Do

Seek specialist veterinary advice immediately if FIP is suspected in your cat
Discuss antiviral treatment options including licensed and compounded medications
Support campaigns for affordable licensed FIP treatment to be available globally
Donate to feline health research organisations advancing FIP treatment knowledge